Razmyar Mohammad, Yazdanpanah Mohammad J, Mashayekhi-Goyonlo Vahid, Khajedaluee Mohammad, Sharifan Payam, Dadgarmoghaddam Maliheh, Ferns Gordon, Ghayour-Mobarhan Majid
Cutaneous Leishmaniasis Research Center, Department of Dermatology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Social Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Indian J Dermatol. 2023 Jan-Feb;68(1):120. doi: 10.4103/ijd.ijd_84_22.
BACKGROUND: Several manifestations of cutaneous leishmaniasis are related to the host's immune system and the species of parasite. OBJECTIVE: There have been some studies on the relationship between vitamin D statuses in infectious diseases including cutaneous leishmaniasis. However, the results of these studies have been inconsistent. MATERIALS AND METHODS: In this cross-sectional study, 147 patients with leishmaniasis were recruited and divided into the following categories: acute cutaneous leishmaniasis (<1 year) ( = 51), chronic cutaneous leishmaniasis (more than 1 year) ( = 26), and leishmaniasis recidivans (the appearance of new papular lesions around a previous scar) ( = 20), and a group of participants without leishmaniasis ( = 50), as a control group. Serum 25-hydroxyvitamin D [25(OH) D] level was analyzed. RESULT: There were significant differences in serum 25(OH) D between the groups with acute or chronic leishmaniasis and those with recidivans leishmaniasis ( = 0.013 and = 0.022, respectively). The median serum level of vitamin D in the acute group was 13.7 ng/mL, in the chronic group was 16.05 ng/mL, in the recidivans group was 21.75 ng/mL, and in the control group was 17.97 ng/mL. CONCLUSION: Higher serum concentrations of 25(OH) vitamin D levels being associated with leishmaniasis recidivans.
J Assoc Physicians India. 2023-1
Arch Iran Med. 2009-7
Can J Physiol Pharmacol. 2015-5
J Neuroimmunol. 2014-3-18
Iran J Basic Med Sci. 2013-3
Trends Parasitol. 2014-1-2
J Steroid Biochem Mol Biol. 2013-12-25
Exp Parasitol. 2013-5-21